191 related articles for article (PubMed ID: 33899909)
1. Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA).
Akbar A; Liu K; Michos ED; Bancks MP; Brubaker L; Markossian T; Durazo-Arvizu R; Kramer H
Am J Hypertens; 2022 Jan; 35(1):22-30. PubMed ID: 33899909
[TBL] [Abstract][Full Text] [Related]
2. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Associated Factors for Overactive Bladder Subtypes in Middle-Aged Women: A Cross-Sectional Study.
Yang CF; Huang CY; Wang SY; Chang SR
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334559
[TBL] [Abstract][Full Text] [Related]
4. Racial Differences in Urinary Incontinence Prevalence, Overactive Bladder and Associated Bother among Men: The Multi-Ethnic Study of Atherosclerosis.
Akbar A; Liu K; Michos ED; Brubaker L; Markossian T; Bancks MP; Kramer H
J Urol; 2021 Feb; 205(2):524-531. PubMed ID: 32909876
[TBL] [Abstract][Full Text] [Related]
5. Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction?
Juliato CRT; Melotti IGR; Junior LCS; Britto LGO; Riccetto CLZ
J Sex Med; 2017 Jul; 14(7):904-909. PubMed ID: 28622875
[TBL] [Abstract][Full Text] [Related]
6. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Urine Choline Levels in Women With and Without Overactive Bladder Syndrome.
Sheyn D; Hijaz AK; Hazlett FE; Dawodu K; El-Nashar S; Mangel JM; Petrikovets A; Mahajan ST
Female Pelvic Med Reconstr Surg; 2020 Oct; 26(10):644-648. PubMed ID: 30212388
[TBL] [Abstract][Full Text] [Related]
8. Overactive bladder in an integrated delivery system: a longitudinal cohort study.
Linder JA; Weissman JS; Reyes Nieva H; Lipsitz S; Haring RS; DeAngelis J; Kristy RM; Loughlin KR
BMC Health Serv Res; 2020 May; 20(1):447. PubMed ID: 32434511
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study.
Coyne KS; Margolis MK; Kopp ZS; Kaplan SA
Urology; 2012 Jan; 79(1):95-101. PubMed ID: 22055692
[TBL] [Abstract][Full Text] [Related]
10. Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey.
Kupelian V; Rosen RC; Roehrborn CG; Tyagi P; Chancellor MB; McKinlay JB
BJU Int; 2012 Aug; 110(3):401-7. PubMed ID: 22176817
[TBL] [Abstract][Full Text] [Related]
11. Severe depression and anxiety in women with overactive bladder.
Melotti IGR; Juliato CRT; Tanaka M; Riccetto CLZ
Neurourol Urodyn; 2018 Jan; 37(1):223-228. PubMed ID: 28407347
[TBL] [Abstract][Full Text] [Related]
12. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
13. Natural history of non-neurogenic overactive bladder and urinary incontinence over 5 years in community-dwelling older men: The concord health and aging in men project.
Noguchi N; Chan L; Cumming RG; Blyth FM; Handelsman DJ; Waite LM; Le Couteur DG; Naganathan V
Neurourol Urodyn; 2017 Feb; 36(2):443-448. PubMed ID: 26756291
[TBL] [Abstract][Full Text] [Related]
14. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response.
Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y
Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
[TBL] [Abstract][Full Text] [Related]
16. Urinary incontinence, overactive bladder, and quality of life in women submitted to total hip replacement.
Martines GA; Tamanini JTN; Mota GMDS; Barreto ET; Santos JLF; Sartori MGF; Girão MJBC; Castro RA
Neurourol Urodyn; 2022 Mar; 41(3):830-840. PubMed ID: 35114028
[TBL] [Abstract][Full Text] [Related]
17. The Prevalence of Overactive Bladder Symptoms in Women in Algeria, Egypt, Jordan and Lebanon: A Cross-Sectional Population-Based Survey.
Al Edwan G; Abdelazim MS; Salhab SE; Jamal YM; Soliman MA
Adv Ther; 2021 Feb; 38(2):1155-1167. PubMed ID: 33354738
[TBL] [Abstract][Full Text] [Related]
18. Sleep Disturbance and Fatigue Are Associated With More Severe Urinary Incontinence and Overactive Bladder Symptoms.
Ge TJ; Vetter J; Lai HH
Urology; 2017 Nov; 109():67-73. PubMed ID: 28826875
[TBL] [Abstract][Full Text] [Related]
19. Urinary Incontinence and Overactive Bladder Symptoms in Women with Breast Cancer Being Treated with Oral Hormone Therapy.
Stahlschmidt R; Ferracini AC; Medeiros LM; Souza CM; Juliato CRT; Mazzola PG
Rev Bras Ginecol Obstet; 2020 Nov; 42(11):726-730. PubMed ID: 33254267
[TBL] [Abstract][Full Text] [Related]
20. National community prevalence of overactive bladder in the United States stratified by sex and age.
Coyne KS; Sexton CC; Vats V; Thompson C; Kopp ZS; Milsom I
Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
